This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on ISI (94)  • Contact me when this article is cited  Related Content  • Related letters  • Similar articles in JAMA  Topic Collections  • Conflict of Interest  • Health Policy  • Medical Ethics  • Alert me on articles by topic

Jason Dana, MS; George Loewenstein, PhD

JAMA. 2003;290:252-255.

	Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

A conflict of interest exists when a primary ethical or professional interest clashes with financial self-interest, a situation that arises commonly in medical practice. When physicians are remunerated for performing specific tests and procedures, they face a conflict of interest when they also recommend those same tests and procedures. When they are paid for referrals to clinical trials, physicians are in the conflicted position of deciding whether their patients are appropriate for the studies. Performing industry-supported research, physicians face an implicit demand for a positive finding to obtain further financial support. And, when pharmaceutical companies court high-volume prescribers, writing prescriptions becomes an act not only with financial and health consequences for patients, but also with financial consequences for the physician. This last source of conflict of interest is the central focus of this commentary.

In discussions of gifts from industry, whether in medical journals, . . . [Full Text of this Article]

Gifts From Industry: A Problem for Policy Makers

Author Affiliation: Department of Social and Decision Sciences, Carnegie Mellon University, Pittsburgh, Pa.

RELATED LETTERS

Psychological Aspects of Gifts From Drug Companies
Dana Katz, Peter Mansfield, Robert Goodman, Leonore Tiefer, and Jon Merz
JAMA. 2003;290(18):2404-2405.
EXTRACT | FULL TEXT  

Psychological Aspects of Gifts From Drug Companies
Michael S. Goldrich
JAMA. 2003;290(18):2405.
EXTRACT | FULL TEXT  

Psychological Aspects of Gifts From Drug Companies
Gary A. Tarshis
JAMA. 2003;290(18):2405.
EXTRACT | FULL TEXT  

Psychological Aspects of Gifts From Drug Companies
Michael Tansey
JAMA. 2003;290(18):2405-2406.
EXTRACT | FULL TEXT  

Psychological Aspects of Gifts From Drug Companies
Louis Bergeron
JAMA. 2003;290(18):2406.
EXTRACT | FULL TEXT  

Psychological Aspects of Gifts From Drug Companies
Chris McCoy and Lauren Oshman
JAMA. 2003;290(18):2406.
EXTRACT | FULL TEXT  

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

New Developments in Managing Physician-Industry Relationships
Rothman and Chimonas
JAMA 2008;300:1067-1069.
FULL TEXT  

Invited Article: Conflicts of interest for authors of American Academy of Neurology clinical practice guidelines
Holloway et al.
Neurology 2008;71:57-63.
ABSTRACT | FULL TEXT  

Hormone Therapy, Dilemmas, Medical Decisions.
Schulkin
J Law Med Ethics 2008;36:73-88.
 

Has the hunt for conflicts of interest gone too far? No
Lee
BMJ 2008;336:477-477.
FULL TEXT  

Institutional Academic Industry Relationships
Campbell et al.
JAMA 2007;298:1779-1786.
ABSTRACT | FULL TEXT  

Experience of VA Psychiatrists With Pharmaceutical Detailing of Antipsychotic Medications
Sernyak and Rosenheck
Psychiatr. Serv. 2007;58:1292-1296.
ABSTRACT | FULL TEXT  

The Sound and the Fury: Financial Conflicts of Interest in Oncology
Djulbegovic et al.
JCO 2007;25:3567-3569.
FULL TEXT  

Attitudes of general dentists regarding the acceptance of gifts and unconventional payments from patients
Reid et al.
Journal of the American Dental Association 2007;138:1127-1133.
ABSTRACT | FULL TEXT  

Follow-Up on Antidepressants During Pregnancy: An Exchange of Views
JWatch Women's Health 2007;2007:6-6.
FULL TEXT  

The High Cost of Free Lunch
Wall and Brown
Obstet Gynecol 2007;110:169-173.
ABSTRACT | FULL TEXT  

Physicians' intent to comply with the American Medical Association's guidelines on gifts from the pharmaceutical industry
Pinto et al.
J. Med. Ethics 2007;33:313-319.
ABSTRACT | FULL TEXT  

The illusion of invulnerability
Mansfield
BMJ 2007;334:1020-1020.
FULL TEXT  

Prescriber Profiling: Time to Call It Quits
Grande
ANN INTERN MED 2007;146:751-752.
FULL TEXT  

Conflicts of Interest and the Physician-Patient Relationship in the Era of Direct-to-Patient Advertising
Jagsi
JCO 2007;25:902-905.
FULL TEXT  

Interactions Between Physicians and Industry: A Guide for Clinicians
Jibson
Focus 2007;5:398-406.
ABSTRACT | FULL TEXT  

Opprobrium or opportunity?
Glick
Journal of the American Dental Association 2006;137:1484-1486.
FULL TEXT  

Interactions of doctors with the pharmaceutical industry.
Morgan et al.
J. Med. Ethics 2006;32:559-563.
ABSTRACT | FULL TEXT  

Symposium. Relationships with Industry: Critical for New Technology or an Unnecessary Evil?
Jacobs et al.
JBJS 2006;88:1650-1663.
FULL TEXT  

Clinical Trial Investigators and Their Prescribing Patterns: Another Dimension to the Relationship Between Physician Investigators and the Pharmaceutical Industry
Psaty and Rennie
JAMA 2006;295:2787-2790.
FULL TEXT  

Health Industry Practices That Create Conflicts of Interest: A Policy Proposal for Academic Medical Centers
Brennan et al.
JAMA 2006;295:429-433.
ABSTRACT | FULL TEXT  

Ties That Bind: Multiple Relationships Between Clinical Researchers and the Pharmaceutical Industry
Henry et al.
Arch Intern Med 2005;165:2493-2496.
ABSTRACT | FULL TEXT  

Pharmacists, pharmaceutical manufacturers, and conflicts of interest
Banks
Am J Health Syst Pharm 2005;62:1827-1832.
FULL TEXT  

New Federal Guidelines For Physician-Pharmaceutical Industry Relations: The Politics Of Policy Formation
Chimonas and Rothman
Health Aff (Millwood) 2005;24:949-960.
ABSTRACT | FULL TEXT  

Recent Developments in Health Law
Moskowitz
J Law Med Ethics 2005;33:168-187.
 

The role of the pharmaceutical industry in neurologic education
Gelb
Neurology 2005;64:E7-E10.
FULL TEXT  

Does the C in CME stand for "Continuing" or "Commercial"?
Lexchin and Cassels
CMAJ 2005;172:160-162.
FULL TEXT  

The Company We Keep: Why Physicians Should Refuse to See Pharmaceutical Representatives
Brody
Ann Fam Med 2005;3:82-85.
ABSTRACT | FULL TEXT  

Doctors and Drug Companies
Blumenthal
NEJM 2004;351:1885-1890.
FULL TEXT  

Financial Conflicts of Interest in Physicians' Relationships with the Pharmaceutical Industry -- Self-Regulation in the Shadow of Federal Prosecution
Studdert et al.
NEJM 2004;351:1891-1900.
FULL TEXT  

Cost-Related Medication Underuse: Do Patients With Chronic Illnesses Tell Their Doctors?
Piette et al.
Arch Intern Med 2004;164:1749-1755.
ABSTRACT | FULL TEXT  

Manufacturing Desire:: The Commodification of Female Sexual Dysfunction
Fishman
Social Studies of Science 2004;34:187-218.
ABSTRACT  

The Anxieties of Globalization:: Antidepressant Sales and Economic Crisis in Argentina
Lakoff
Social Studies of Science 2004;34:247-269.
ABSTRACT  

Psychological Aspects of Gifts From Drug Companies
Goldrich
JAMA 2003;290:2405-2405.
FULL TEXT  

Psychological Aspects of Gifts From Drug Companies
Bergeron
JAMA 2003;290:2406-2406.
FULL TEXT  

Psychological Aspects of Gifts From Drug Companies
Katz et al.
JAMA 2003;290:2404-2405.
FULL TEXT  

Psychological Aspects of Gifts From Drug Companies
Tarshis
JAMA 2003;290:2405-2405.
FULL TEXT  

Psychological Aspects of Gifts From Drug Companies
Tansey
JAMA 2003;290:2405-2406.
FULL TEXT  

Psychological Aspects of Gifts From Drug Companies
McCoy and Oshman
JAMA 2003;290:2406-2406.
FULL TEXT  

Policies to Regulate Gifts to Physicians From Industry
Tsai
JAMA 2003;290:1776-1776.
FULL TEXT